Human medicines European public assessment report (EPAR): Axitinib Accord, axitinib, Status: Opinion

Human medicines European public assessment report (EPAR): Anzupgo, Delgocitinib, Status: Opinion

Human medicines European public assessment report (EPAR): Iqirvo, Elafibranor, Status: Opinion

Human medicines European public assessment report (EPAR): Kayfanda, odevixibat, Status: Opinion

Human medicines European public assessment report (EPAR): Loqtorzi, Toripalimab, Status: Opinion

Human medicines European public assessment report (EPAR): Vevizye, ciclosporin, Status: Opinion

Human medicines European public assessment report (EPAR): Vyloy, Zolbetuximab, Status: Opinion

Human medicines European public assessment report (EPAR): Yuvanci, macitentan,tadalafil, Status: Opinion

Human medicines European public assessment report (EPAR): Eksunbi, ustekinumab, Status: Opinion

Human medicines European public assessment report (EPAR): Ituxredi, rituximab, Status: Opinion